跳至主要内容
临床试验/NCT00468754
NCT00468754已完成不适用

A Study Comparing Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections With Insulin Lispro and Glargine

Hoffmann-La Roche4 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2003年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
4
主要终点
Variability of blood glucose characterised by the standard deviation of the mean blood glucose

研究概览

简要总结

This trial will compare the metabolic control in type 1 diabetes obtained by continuous infusion of insulin lispro with that obtained by multiple daily injections of insulin lispro and glargine, a long-acting insulin analogue. Patients will be switched to the alternative treatment after 4 months. Glucose variability in the last month of each treatment will be analyzed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Type 1 diabetic patients, 18-60 years of age
  • •Diabetic for >2 years
  • •Treated with CSII for >=6 months
  • •HbA1c <8.5%

排除标准

  • •Treatment with daily insulin injections
  • •Inability to handle pump therapy
  • •Untreated retinopathy

研究组 & 干预措施

A

Experimental

干预措施: Insulin pumps (Device)

B

Experimental

干预措施: Insulin pumps (Device)

结局指标

主要结局

Variability of blood glucose characterised by the standard deviation of the mean blood glucose

时间窗: Length of study

次要结局

  • HbA1c(Length of study)
  • Frequency of severe hypoglycemia(Length of study)
  • Daily insulin requirement(Length of study)
  • Mean BG during the last month of the respective treatment period(Length of study)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

A Study Comparing Continuous Subcutaneous Insulin... | 临床试验